-
Mashup Score: 1Supremacy of Non-Surgical Interventions for Patients With Stage 3 Non-Small Cell Lung Cancer - 2 hour(s) ago
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Charles Simone, MD, argued that surgical approaches have a limited role in the treatment of patients with stage 3 non-small cell lung cancer.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Revisit Every OncLive On Air Episode from March 2024 - 2 hour(s) ago
In case you missed any, below is a recap of every episode of OncLive On Air that aired in March 2024.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia - 2 hour(s) ago
Pediatric MLLT10+ AML have poor prognosis and may benefit from targeted therapies.Patients with PICALM::MLLT10+ and X::MLLT10+ exhibit DNA hypermethylation
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0ARPA-H’s Andrew Carney: Join the AI Cyber Challenge to counter cyberattacks on health systems - The Cancer Letter - 2 hour(s) ago
Can AI-enabled technology safeguard hospitals, pharmacies, and medical devices from cyberattacks? To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.Login Subscribe
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
HHV-6B reactivation affects approximately half of all allogeneic hematopoietic cell transplant (HCT) recipients. HHV-6B is the most frequent infectious cause of encephalitis following HCT and is associated with pleiotropic manifestations in this setting, including graft-versus-host disease, myelosuppression, pneumonitis, and CMV reactivation, although the causal link is not always clear. When the virus inserts its genome in chromosomes of germ cells, the chromosomally integrated form (ciHHV6) is inherited by offspring. The condition of ciHHV6 is characterized by the persistent detection of HHV-6 DNA, often confounding diagnosis of reactivation and disease—this has also been associated with adverse outcomes. Recent changes in clinical practice in the field of cellular therapies, including a wider use of post-HCT cyclophosphamide, the advent of letermovir for CMV prophylaxis, and the rapid expansion of novel cellular therapies require contemporary epidemiological studies to determine the
Source: www.mdpi.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Breast Relapse of Pediatric B-Cell Acute Lymphoblastic Leukemia After CAR-T Therapy Detected by 18F-FDG PET/CT - 2 hour(s) ago
Background: B-cell acute lymphoblastic leukemia (B-ALL) is the most common childhood malignancy. Medullary and extramedullary disease relapse is a well-known occurrence in B-ALL pediatric patients treated with standard chemo-immunotherapy and, more recently, with chimeric antigen receptor (CAR)-T cell therapy. 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) emerges as a sensitive imaging tool for detecting disease relapse at extra-medullary sites, with only limited literature evidence in the CAR-T therapy setting. Case Report: In a 12-year-old female treated with CAR-T therapy for B-ALL relapse, 18F-FDG PET/CT scan performed for surveillance, after disease remission, detected a solitary and clinically occult relapse in the breast parenchyma that was histologically confirmed. Conclusion: At our knowledge, this is the first report about a pediatric B-ALL patient with a solitary and occult breast relapse after CAR-T therapy, early discovered by 18F
Source: ar.iiarjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0What does ovarian cancer pain feel like? - 3 hour(s) ago
What does ovarian cancer pain feel like? Gynecologic oncologist and surgeon Pamela Soliman, M.D., weighs in on this and four other questions.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Key Findings from COMFORT I and II Trials - 3 hour(s) ago
Dr. Bose discusses the key findings from the COMFORT I and II trials and how the overall survival data has impacted the way he manages patients with myelofibrosis, along with the factors that most inform his treatment decisions.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Featured Articles Archive - 4 hour(s) ago
2023 Featured Articles July 13 – Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial Citation: van Hemert, A.K.E., van Duijnhoven, F.H., van Loevezijn, A.A. et al. Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial. Ann Surg Oncol 30, 4682–4689 … Featured Articles Archive Read More »
Source: www.surgonc.orgCategories: General Medicine News, Onc News and JournalsTweet
At #GDULC Charles Simone, MD, argued that surgical approaches have a limited role in the treatment of patients with stage 3 NSCLC. Learn more: https://t.co/OlQo8IxBF3 #medtwitter #onctwitter https://t.co/NbGRJJ82UE